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Chlamydia trachomatis is an obligate intracellular bacterium with a distinctive biphasic 26 
developmental cycle that alternates between two distinct cell types; the extracellular 27 
infectious elementary body (EB) and the intracellular replicating reticulate body (RB). 28 
Members of the genus Chlamydia are dependent on the formation and degradation of 29 
protein disulfide bonds. Moreover, disulfide cross-linking of EB envelope proteins is critical 30 
for the infection phase of the developmental cycle. We have identified in C. trachomatis a 31 
homologue of the Disulfide Bond forming membrane protein Escherichia coli (E. coli) 32 
DsbB (hereafter named CtDsbB) and - using recombinant purified proteins - demonstrated 33 
that it is the redox partner of the previously characterised periplasmic oxidase C. 34 
trachomatis Disulfide Bond protein A (CtDsbA). CtDsbA protein was detected in C. 35 
trachomatis inclusion vacuoles at 20 h post infection, with more detected at 32 and similar 36 
levels at 44 h post infection as the developmental cycle proceeds. As a redox pair, CtDsbA 37 
and CtDsbB largely resemble their homologous counterparts in E. coli; CtDsbA is directly 38 
oxidised by CtDsbB, in a reaction in which both periplasmic cysteine pairs of CtDsbB are 39 
required for complete activity. In our hands, this reaction is slow relative to that observed 40 
for E. coli equivalents, although this may reflect a non-native expression system and use 41 
of a surrogate quinone cofactor. CtDsbA has a second non-catalytic disulfide bond, which 42 
has a small stabilising effect on the protein’s thermal stability, but which does not appear 43 
to influence the interaction of CtDsbA with its partner protein CtDsbB. Expression of 44 
CtDsbA during the RB replicative phase and during RB to EB differentiation coincided with 45 
the oxidation of the chlamydial outer membrane complex (COMC). Together with our 46 
demonstration of an active redox pairing, our findings suggest a potential role for CtDsbA 47 
and CtDsbB in the critical disulfide bond formation step in the highly regulated 48 




Disulfide bonds add structural bracing to proteins, conferring rigidity and stability. The 51 
presence or absence of such structural disulfide bonds varies markedly by cellular 52 
compartment. In both bacteria and eukaryotes, structural disulfide bonded proteins are 53 
rarely found in the cytoplasm, but instead are prevalent in more oxidising environments. In 54 
prokaryotes, disulfide bond proteins are thus found in the periplasm, membrane, and among 55 
those proteins secreted into the extracellular environment [1]. This distribution of disulfide-56 
bonded proteins reflects the necessity for additional robustness among these proteins to 57 
withstand environmental stresses (e.g. extreme pH, ionic stresses, proteases etc). Many of 58 
these disulfide bonded proteins play a role in bacterial pathogenicity. For example, disulfide 59 
bonds are required for the function and activity of adhesins [2], proteases [3], toxins [4] and 60 
other virulence factors [5, 6] (reviewed in [7] and [1]). Accordingly, bacteria in which 61 
members of the protein disulfide oxidative pathway have been deleted show disrupted 62 
virulence phenotypes in vitro [7-11] and are attenuated in several mouse models of infection 63 
[12-14]. 64 
 65 
For Chlamydia spp, disulfide bonding has additional significance; as well as being required 66 
for infectivity [15], disulfide bonding of the outer membrane proteins is cyclically regulated 67 
during the bacteria’s unique biphasic developmental cycle [15-19] (and reviewed in [20]). 68 
Briefly, members of the genus Chlamydia alternate between two distinct cell types: the 69 
extracellular infectious elementary body (EB) and the intracellular replicating reticulate body 70 
(RB). The Chlamydia EB is rigid, as a result of substantial disulfide bond cross linking within 71 
and between proteins associated with the outer membrane. Collectively these proteins are 72 
the Chlamydia Outer Membrane Complex (COMC), comprised of the Major Outer 73 
Membrane Protein (MOMP), two cysteine rich proteins (OmcA and OmcB), the polymorphic 74 
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membrane proteins (Pmps) (except PmpD), PorB, OprB, Pal, Omp85, CTL0887, CTL0645 75 
and the type III secretion system components CdsC, CdsD and CdsF. The COMC proteins 76 
in the EB envelope are heavily cross-linked with disulfides and this feature is critical for the 77 
infectious phase of the bacteria [17-19, 21-23].  78 
 79 
Disulfide bond protein A (DsbA) is the primary oxidase in the disulfide oxidative pathway of 80 
bacteria [24]. DsbA catalyses the introduction of disulfide bonds into reduced and folding 81 
proteins in concert with a membrane protein partner DsbB. DsbB uses a quinone cofactor 82 
as an electron acceptor, and together the DsbA-DsbB pair ultimately shuttle electrons from 83 
a reduced protein substrate to molecular oxygen via the respiratory pathway [25, 26]. 84 
 85 
Escherichia coli DsbA (EcDsbA) was the first DsbA enzyme to be structurally and 86 
functionally characterised and serves as the canonical model for DsbA enzymes [24, 27, 87 
28]. Briefly, this classic DsbA structure consists of a thioredoxin domain and an inserted α-88 
helical bundle domain. The enzyme’s active site is a Cys-Xaa-Xaa-Cys motif located at the 89 
N-terminus of helix H1. The sequence of the Xaa-Xaa dipeptide modulates the redox 90 
character of the enzyme [29]. The catalytic surface of the protein features 3 loops: Loop 1, 91 
(linking helix H1 and β-strand B3), Loop 2 (linking helix H6 and β-strand B4) which contains 92 
a highly conserved cisPro residue, and Loop 3 (linking helix H7 and β-strand B5.) Together 93 
these loops govern the enzyme’s redox properties and its interactions with protein 94 
substrates (reviewed in [30] and [31]). 95 
 96 
Structural and biochemical characterisation of a library of bacterial DsbA proteins has 97 
revealed that although DsbA proteins from diverse bacterial species share the core structure 98 
described for EcDsbA, they exhibit variations in topology and surface features, resulting in 99 
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structural differences and a nuanced range of redox character and reactivity [31]. This led 100 
to description of a classification system of DsbA proteins in which the proteins are broadly 101 
divided into two groups: DsbA-I and DsbA-II [31].  102 
 103 
Within the DsbA-II group of DsbA proteins, four proteins have been reported that have a 104 
second, non-catalytic disulfide, in addition to the enzymatically critical active site disulfide. 105 
These are DsbA proteins from Pseudomonas aeruginosa (PaDsbA2 [32]), Wolbachia 106 
pipientis (WpDsbA1 [33]), Mycobacterium tuberculosis (MtbDsbA [34, 35]) and Chlamydia 107 
trachomatis (CtDsbA [36]). In each case, this non-catalytic disulfide staples H3 and H5 of 108 
the inserted alpha-helix domain. The functional significance of this second bond appears to 109 
be variable, with evidence for a potential regulatory role, and influence on redox potential 110 
differing between the different enzymes studied to date [32, 33]. While CtDsbA shares 111 
common structural and biochemical features with the DsbA-II group of DsbA proteins, 112 
especially, CtDsbA shares just 15 % sequence identity with the canonical EcDsbA protein 113 
and approximately 20 % sequence identity with other members of the structurally 114 
characterised DsbA-II class proteins that contain a second disulfide [36]. 115 
 116 
We have previously characterised CtDsbA and shown it to be mildly oxidising (redox 117 
potential of -220 mV, compared to that of -120 mV for EcDsbA [36]). Given the importance 118 
of disulfide crosslinking of the Chlamydia envelope in infection and Chlamydia development, 119 
we sought to explore the potential role of CtDsbA in chlamydial envelope disulfide bonding. 120 
We further sought to query the role of the second non-catalytic disulfide in CtDsbA and 121 





CtDsbA is expressed early in the Chlamydial trachomatis 125 
developmental cycle 126 
As an initial exploration of the biological role of CtDsbA, we first investigated when in the 127 
chlamydial developmental cycle CtDsbA is expressed. Using an antibody generated using 128 
recombinant CtDsbA as an antigen, we monitored the expression levels of CtDsbA protein 129 
following infection of McCoy B cells within the C. trachomatis inclusion vacuole and whole 130 
culture extracts (Figs 1 and 2). For Western Blot analysis, antibodies targeting the major 131 
outer membrane protein (MOMP) and RNA polymerase beta (RpoB) were used to adjust 132 
the loading of whole cell lysates (WCLs) to bring levels at the typically low abundant 20 h PI 133 
time point to closer to that of later stages. CtDsbA protein was able to be clearly detected at 134 
32 h post infection (h PI) by Western blot (Fig 1). It appears that the CtDsbA protein may 135 
also be present at 20 h PI, although the signal is faint. Confocal imaging using the same 136 
anti-CtDsbA antibody and a green Alexa Fluor labelled secondary antibody, detected 137 
CtDsbA at 20 h post infection but not in the uninfected controls, indicating that some CtDsbA 138 
protein is present at this time point (Fig 2). At 32 h and 44 h post infection the expression of 139 
CtDsbA is clearly present in the inclusion vacuoles (Fig 2). An antibody specific to C. 140 
trachomatis HtrA (CtHtrA) was additionally used as a positive labelling control, as this 141 
antibody has previously been shown to detect C. trachomatis at the infection time points 142 
analysed [37]. We note that at the 20 h stage of the chlamydial developmental cycle, RB 143 
replication is dominant and that the asynchronous conversion to elementary body EB begins 144 
around this time, including oxidation of the disulfides in the chlamydial outer membrane 145 
complex [38, 39]. Given the possible correlation between CtDsbA expression and onset of 146 
disulfide cross-linking of the proteins in the chlamydial envelope, we hypothesised that a 147 
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DsbA-DsbB redox relay might be involved in the regulation of the disulfide bond status of 148 
the chlamydial outer membrane complex and sought to identify a potential DsbB protein in 149 
C. trachomatis. 150 
 151 
Fig 1. Detection of DsbA protein in C. trachomatis by Western blot. McCoy B cells were 152 
infected with C. trachomatis and harvested 20 h, 32 h and 44 h post infection (h PI). CtDsbA 153 
was detected by Western blot with an anti-CtDsbA antibody raised in rabbit and a 154 
horseradish peroxidase linked secondary antibody (lower left panel). Purified recombinant 155 
CtDsbA protein was probed with the same antibodies for reference (right panel). Detection 156 
of Chlamydia loading control proteins RpoB and MOMP are also shown (upper two panels). 157 
The molecular weight (MW) of the protein standards is indicated in kilodaltons (kDa). 158 
 159 
Fig 2. Detection of DsbA protein in C. trachomatis by confocal microscopy. Confocal 160 
images were obtained of C. trachomatis infected McCoy B cells harvested at 20 h, 32 h and 161 
44 h post infection (h PI), in addition to an uninfected control. CtDsbA and CtHtrA are stained 162 
with anti-CtDsbA and anti-CtHtrA antibodies respectively raised in rabbit, with a secondary 163 
goat anti-rabbit IgG - Alexa Fluor 488 (green). The host cell nucleus is stained with the 164 
fluorescent dye DAPI (blue) that binds strongly to A-T rich regions in DNA. Host cell 165 
cytoskeleton is stained with Alexa Fluor 594 Phalloidin (red) that has high affinity for F-actin.  166 
 167 
C. trachomatis encodes a homologue of DsbB 168 
A protein BLAST interrogation of the C. trachomatis genome (NCBI Taxid: 813) using E. coli 169 
DsbB (EcDsbB, UniProt ID P0A6M2) as the query sequence identified a protein of 135 170 
amino acids with 22 % sequence identity to EcDsbB (Fig 3). This protein will be referred to 171 
hereafter as C. trachomatis DsbB (CtDsbB). CtDsbB is predicted to have four 172 
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transmembrane helices (TM1-4) and two periplasmic loops (P1 and P2), equivalent to the 173 
topology of EcDsbB [40, 41]. However, the predicted loop P2 is significantly shortened in 174 
CtDsbB (14 residues) relative to its E. coli counterpart (49 residues) (Fig 3). CtDsbB has ten 175 
cysteine residues compared to six cysteine residues in EcDsbB. Five of the cysteines in 176 
CtDsbB are embedded in the predicted transmembrane regions and one is located in the 177 
predicted cytoplasmic N-terminal region. Similar to the arrangement of the catalytic 178 
cysteines in EcDsbB, the remaining four cysteines are located in the two predicted 179 
periplasmic loops, and at the N-terminal end of TM2. In EcDsbB, these 4 cysteines constitute 180 
two functional pairs that mediate a series of thiol-exchange reactions facilitating oxidation of 181 
EcDsbA. Conservation of Arg48 and Met142, residues proposed to be involved in 182 
ubiquinone binding in EcDsbB, suggests that CtDsbB is likewise capable of binding a similar 183 
co-factor. The similarity in sequence and topology with EcDsbB suggest that CtDsbB is a 184 
redox partner for CtDsbA. 185 
 186 
Fig 3. Sequence alignment of DsbB from E. coli and C. trachomatis. Sequence 187 
alignment of EcDsbB and CtDsbB performed in AlignMe [42] and visualised using ESPript 188 
[43]. Membrane topology prediction (TMHMM [44]) indicates that CtDsbB (purple), like 189 
EcDsbB (blue), has four predicted transmembrane helices, TM1-4 and two predicted 190 
periplasmic regions P1 and P2 (indicated with an arrow) each containing two cysteine 191 
residues. Annotation of predicted transmembrane boundaries was informed by TMHMM 192 
sequence analysis (for both CtDsbB and EcDsbB), and the observation of alpha helices in 193 
an available crystal structure (EcDsbB) [40]. Cysteine residues are highlighted in each 194 
sequence (purple or blue as above). Residues with strict identity are shown as filled red 195 
boxes and a white character. Residues that are highly similar (above the 0.7 equivalence 196 
threshold) are shown as red character. Residues with weakly similar properties (below the 197 
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0.7 equivalence threshold) are shown as black characters. The conserved residues Arg48 198 
and Met142 are highlighted with an asterisk. 199 
Membranes containing CtDsbB can sustain CtDsbA catalysed 200 
oxidation of a model substrate 201 
To test if CtDsbB is indeed a redox partner of CtDsbA, we recombinantly overexpressed 202 
CtDsbB in E. coli. Crude membrane extracts containing CtDsbB were assayed for their 203 
ability to sustain CtDsbA catalysed oxidation of a model peptide substrate. Briefly, in this 204 
assay purified DsbA catalyses the oxidation of an intramolecular disulfide bond in an initially 205 
reduced and unfolded peptide substrate containing two cysteine residues. Upon folding, a 206 
fluorescence signal can be measured between DOTA-europium and coumarin labels on the 207 
N and C termini, respectively, of the substrate. 8 μM CtDsbB in crude E. coli membranes 208 
successfully sustained CtDsbA (640 nM) oxidase activity (Fig 4A), although at a reduced 209 
rate relative to a positive control containing EcDsbA at an 8-fold lower concentration (80 nM 210 
EcDsbA and 8 μM EcDsbB). Essentially no oxidation of the substrate peptide was observed 211 
in control reactions containing buffer, CtDsbA, or CtDsbB alone.  212 
 213 
Fig 4. Both periplasmic disulfide bonds are required for CtDsbB to form a redox relay 214 
with CtDsbA. An increase in fluorescence as a function of time is seen as a result of CtDsbA 215 
and CtDsbB catalysed oxidation of a fluorescently labelled peptide containing two cysteines. 216 
A) A rapid increase in fluorescence is seen for 80 nM EcDsbA with membranes containing 217 
8 μM EcDsbB (green). 640 nM CtDsbA with membranes containing 8 μM CtDsbB (red) gives 218 
a slower increase in fluorescence. Fluorescence only increases minimally for control 219 
reactions containing only CtDsbB (8 μM) membranes (brown), 640 nM CtDsbA (grey) or 220 
buffer only (black). B) The increase in fluorescence for 640 nM CtDsbA with membranes 221 
containing 8 μM CtDsbB-CCSS (blue) and 640 nM CtDsbA with membranes containing 8 222 
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μM CtDsbB-SSCC (purple) are significantly slower than 640 nM CtDsbA with membranes 223 
containing 8 μM CtDsbB (red), but marginally faster than 640 nM CtDsbA with membranes 224 
containing 8 μM BpsDsbB-SSSS (pink) and buffer only (black). The curves for 80 nM 225 
EcDsbA with membranes containing 8 μM EcDsbB (green), 640 nM CtDsbA with 226 
membranes containing 8 μM CtDsbB (red) and buffer only (black) are the same as in A. 227 
Plotted data show mean and SD for two biological replicates. 228 
 229 
In E. coli both periplasmic loop cysteine pairs of EcDsbB participate in the mechanism of 230 
EcDsbA oxidation [45-47]. To investigate whether the mechanism of CtDsbA oxidation by 231 
CtDsbB is similar to that of E. coli, two CtDsbB mutants were designed in which the cysteines 232 
in loop P1 and loop P2, respectively, are mutated to serines. In CtDsbB-SSCC, periplasmic 233 
loop 1 Cys36 and Cys39 are mutated to serines. In CtDsbB-CCSS, periplasmic loop 2 Cys98 234 
and Cys104 are mutated to serines. In the presence of CtDsbB-CCSS or CtDsbB-SSCC, 235 
CtDsbA catalysed oxidation of the peptide substrate is markedly reduced relative to wild-236 
type CtDsbB, although oxidation proceeds more rapidly than observed for negative controls 237 
containing only buffer, or the wild-type CtDsbB variant alone (Fig 4B). That CtDsbA is 238 
significantly less active in the presence of CtDsbB-SSCC or CtDsbB-CCSS, than in the 239 
presence of CtDsbB, suggests that as anticipated, the disulfide bonds present in periplasmic 240 
loops P1 and P2 are each required for complete oxidation of CtDsbA. 241 
 242 
Although much less active than in the presence of CtDsbB, reactions of CtDsbA with 243 
membranes containing CtDsbB-SSCC and CtDsbB-CCSS did show some activity relative 244 
to the buffer control (Fig 4B). To exclude the possibility that other factors present in the E. 245 
coli membranes facilitate CtDsbA activity, a catalytically inactive construct of a DsbB from 246 
another organism, Burkholderia pseudomallei with all four cysteines in the two periplasmic 247 
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loops mutated to serines (BpsDsbB-SSSS)[13] was included as a negative control (Fig 4B). 248 
Membranes containing catalytically inactive BpsDsbB-SSSS were also unable to facilitate 249 
CtDsbA activity, and most closely resembled the reaction containing buffer alone. 250 
Consequently, the observed CtDsbA activity arises from a specific interaction with CtDsbB, 251 
and other factors in the membrane preparation contribute minimally to CtDsbA activity. 252 
Taken together, this activity is consistent with CtDsbB being a redox partner protein of 253 
CtDsbA. 254 
 255 
Detergent solubilised, purified CtDsbB partially oxidises 256 
reduced CtDsbA  257 
To confirm that CtDsbA oxidising activity in the model substrate assay is sustained 258 
specifically by interaction with CtDsbB in the membranes, we examined the redox state of 259 
recombinant purified CtDsbA following incubation with detergent solubilised purified 260 
CtDsbB. The redox state of CtDsbA was assessed using an electrophoretic mobility assay. 261 
Briefly, CtDsbA was treated with the thiol-reactive probe 4-Acetamido-4'-262 
Maleimidylstilbene`-2,2'-Disulfonic Acid (AMS), which labels free thiols and adds 0.5 kDa 263 
per label to the molecular weight. This allows oxidised CtDsbA and reduced CtDsbA to be 264 
separated by SDS-PAGE, and their relative abundance quantified by densitometric analysis. 265 
 266 
As we hypothesised that the active site CSAC thiols are the likely target for CtDsbB 267 
mediated oxidation, we first used a construct of CtDsbA in which the three non-catalytic 268 
cysteines in the protein were changed to serine (CtDsbA-SSS; [36]) Reduced CtDsbA-SSS 269 
was incubated with ubiquinone-1 (UQ1) in the presence or absence of equimolar amounts 270 
of purified, detergent-solubilised CtDsbB.  After mixing, a sample was taken immediately, 271 
and after subsequent time points, as indicated in Fig 5. At each time point the reaction was 272 
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stopped by precipitation with trichloroacetic acid (10% w/v) and the samples subsequently 273 
treated with AMS.  274 
 275 
Fig 5. Detergent solubilised, purified CtDsbB partially oxidises CtDsbA-SSS 276 
independently of exogenous ubiquinone. The redox state of CtDsbA-SSS over time was 277 
monitored by a shift in electrophoretic mobility after treatment with the alkylating agent AMS 278 
that adds 0.5 kDa per reduced cysteine. A) Reduced CtDsbA-SSS (15 μM) was incubated 279 
with equimolar purified detergent solubilised CtDsbB (15 μM) in the absence or presence of 280 
UQ1 (15 μM) and incubated over the indicated time course. Oxidised CtDsbA-SSS is 281 
detectable after 10 min in the presence of CtDsbB (left hand side of gel) and was not affected 282 
by the addition of exogenous UQ1 (right hand side of gel). Completely reduced and oxidised 283 
CtDsbA-SSS protein samples were included on the SDS-PAGE for reference. These 284 
samples contained 5mM DTT and 5 mM oxidised glutathione respectively to keep CtDsbA-285 
SSS reduced and oxidised throughout the 120 min incubation. Incubation of reduced 286 
CtDsbA-SSS with 15 μM UQ1 showed a small fraction of oxidised CtDsbA-SSS formed over 287 
the 120 min time course. Data presented is representative of three independent experiments 288 
from three different purifications of recombinant CtDsbA-SSS and CtDsbB, expressed 289 
following independent transformations of E. coli. 290 
 291 
For CtDsbA-SSS incubated with CtDsbB and UQ1, the protein initially migrates at a 292 
molecular weight corresponding to reduced CtDsbA-SSS (red CtDsbA-SSS) until 10 293 
minutes after the reaction is started, at which point CtDsbA-SSS migrates as two bands, 294 
corresponding to a mixture of oxidised (ox CtDsbA-SSS) and reduced protein. After 120 295 
min, only half of the CtDsbA-SSS has been oxidised by CtDsbB in the presence of 296 
exogenous UQ1 (Fig 5). This reaction proceeds slowly as compared to EcDsbA and EcDsbB 297 
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where in an equivalent experiment in the presence of exogenous UQ1, essentially all 298 
reduced EcDsbA is converted to the oxidised form in 10 seconds, with a minor population 299 
participating in the formation of a EcDsbA-EcDsbB complex [48]. Of note, in our hands the 300 
oxidation of reduced CtDsbA-SSS proceeds similarly in the presence and absence of 301 
exogenous UQ1, suggesting that exogenous UQ1 is not required for the reaction to proceed, 302 
although in neither case is reduced CtDsbA-SSS fully converted to oxidised over the 120 303 
min period. Notably, when reduced CtDsbA-SSS was incubated in the presence of UQ1 304 
alone i.e. without DsbB, a small fraction of CtDsbA-SSS was oxidised over the time course 305 
(120 min.) Taken together with the model substrate oxidation, these data suggest that 306 
CtDsbA and CtDsbB can form a functional relay, although UQ1 is likely not the ideal quinone 307 
for the reaction as evidenced by the relatively slow rates of reaction and that the redox 308 
conversion does not go to completion under the experimental conditions used.  309 
Unpicking the role of the second disulfide in CtDsbA 310 
Next, we investigated the contribution of the second disulfide bond to CtDsbA’s redox 311 
character and activity. In Wolbachia pipientis DsbA1 (WpDsbA1), an equivalent non-312 
catalytic secondary disulfide may have a regulatory role by autoinhibiting the interaction of 313 
WpDsbA1 with its partner W. pipientis DsbB [49], and a very modest effect on redox potential 314 
[33]. In contrast, mutation of the secondary disulfide in P. aeruginosa PaDsbA2 influences 315 
the protein’s redox potential significantly [32]. We sought to answer what role this second 316 
disulfide may play in CtDsbA, by investigating whether its removal affected CtDsbA’s 317 
interaction with CtDsbB, or altered the protein’s thermal stability of its reduced and oxidised 318 
states. 319 
 320 
To explore the potential for the second disulfide to modulate interaction with CtDsbB, we 321 
compared the activity of CtDsbA-SSS (containing only the active site disulfide) and wild type 322 
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CtDsbA (containing both the active site, secondary disulfide and an unpaired cysteine) in 323 
the model peptide substrate assay. CtDsbA-SSS and wild-type CtDsbA are equally active 324 
in their oxidation of the model substrate, suggesting that the second disulfide does not affect 325 
interaction with CtDsbB in this assay, at least not in the presence of the endogenous quinone 326 
available in the membrane preparation (Fig 6A). We note the possibility that addition of an 327 
exogenous ideal quinone may reveal reaction differences between the protein variants.  328 
 329 
Fig 6. The second disulfide of CtDsbA does not influence interaction with CtDsbB. A) 330 
An increase in fluorescence as a function of time is seen as a result of CtDsbA or CtDsbA-331 
SSS catalysed oxidation of a fluorescently labelled peptide containing two cysteines. A rapid 332 
increase in fluorescence is seen for positive control 80 nM EcDsbA with membranes 333 
containing 8 μM EcDsbB (green). The activity of 640 nM CtDsbA (red) and 640 nM CtDsbA-334 
SSS (blue) is equivalent upon interaction with membranes containing 8 μM CtDsbB. The 335 
activity of CtDsbB (grey) is only minimally higher than fluorescence for the buffer only control 336 
(black). Plotted data show mean and SD for three biological replicates, except for the 337 
EcDsbA + EcDsbB control where data from a single experiment was used. B) Reduced 338 
CtDsbA (15 μM) was incubated with equimolar purified detergent solubilised CtDsbB (15 339 
μM) in the absence or presence of UQ1 (15 μM) and incubated over the indicated time 340 
course. Oxidised CtDsbA was detected after 10 min in the presence of CtDsbB (left hand 341 
side of gel) and did not require exogenous UQ1 for the reaction to proceed (right hand side 342 
of gel). Completely reduced and oxidised CtDsbA-SSS protein samples were included on 343 
the SDS-PAGE for reference. These samples contained 5mM DTT and 5 mM oxidised 344 
glutathione respectively to keep CtDsbA-SSS reduced and oxidised throughout the120 min 345 
incubation.15 μM UQ1 alone was not able to oxidise CtDsbA over the 120 min time course. 346 
Data presented is representative of three independent experiments from three different 347 
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purifications of recombinant CtDsbA and CtDsbB expressed following independent 348 
transformations of E. coli. 349 
 350 
Similarly, we assessed whether CtDsbB mediated oxidation of reduced wild type CtDsbA 351 
and reduced CtDsbA-SSS proceeded equivalently using the electrophoretic mobility assay. 352 
We showed previously that detergent solubilised CtDsbB was able to oxidise CtDsbA-SSS 353 
without the addition of exogenous UQ1 (Fig 5). Here, CtDsbB was also able to oxidise 354 
reduced wild type CtDsbA in the presence or absence of exogenous UQ1 (Fig 6B), indicating 355 
that exogenous UQ1 is not required for the reaction to proceed. Once again, under these 356 
experimental conditions, a mixture of oxidised and reduced CtDsbA remained after 120 min. 357 
One difference however, was that reduced wild type CtDsbA was not readily oxidised by 358 
exogenous UQ1 alone, indicating that the oxidation reaction is predominantly mediated by 359 
CtDsbB. 360 
 361 
Reduction and oxidation of disulfide bonds in proteins can change a protein’s melting 362 
temperature (Tm), i.e. the temperature at which half of the protein is unfolded. Typically, in 363 
DsbA proteins, reduction of the active site disulfide increases the melting temperature, 364 
reflecting the greater stability of the reduced form of the protein relative to the oxidised form, 365 
consistent with a thermodynamic favourability for the enzyme to oxidise substrates and itself 366 
become reduced. We have previously determined the melting temperature for reduced and 367 
oxidised CtDsbA as 339 ± 0.2 K and 335 ± 0.1 K, respectively; this is one of the smaller 368 
differential Tm values reported for DsbA proteins [36]. The melting temperature of reduced 369 
CtDsbA-SSS was determined as for wild-type using a gradual temperature ramp and 370 
monitoring protein unfolding by circular dichroism spectroscopy. The melting temperature of 371 
reduced CtDsbA-SSS was determined as 336K ± 0.1, and that of the oxidised state 334K 372 
16 
 
± 0.2 (Fig 7). As for other DsbA proteins, the melting temperature of the reduced protein is 373 
greater, indicating that the reduced state has a greater thermal stability than the oxidised 374 
state. As only the active site disulfide can form in this construct, this is consistent with the 375 
relative thermodynamically favoured reduced state of the enzyme. The difference in Tm 376 
between the two states is again modest (~2 K), and indeed smaller than that observed for 377 
wild-type protein (4 K [36]). 378 
 379 
Fig 7. The second disulfide of CtDsbA has a limited effect on protein thermal stability. 380 
The thermal unfolding of reduced and oxidised CtDsbA-SSS was monitored by CD 381 
spectroscopy and the fraction of unfolded CtDsbA-SSS plotted as a function of temperature. 382 
With a melting temperature of 336 K ± 0.1, reduced CtDsbA-SSS is slightly more stable than 383 
oxidised CtDsbA-SSS that has a melting temperature of 334 K ± 0.2. Plotted data show 384 
mean and SD for three biological replicates. 385 
 386 
The reduced difference in Tm between the reduced and oxidised states of CtDsbA-SSS 387 
(∆Tm = 2 K), compared to reduced and oxidised CtDsbA (∆Tm = 4 K) suggests that the non-388 
catalytic disulfide contributes somewhat to the relative stability of the oxidised and reduced 389 
states i.e. either by additionally stabilising the reduced form, or further destabilising the 390 
oxidised.  391 
 392 
As reduced wild type CtDsbA (in which both active site and non-catalytic disulfides are 393 
reduced) and reduced CtDsbA-SSS (in which the active site disulfide is reduced, and the 394 
reduced second disulfide is mimicked by cysteine-to-serine mutations) both represent 395 
proteins in which both disulfides are effectively in the reduced state, it was surprising that 396 
the melting temperature for reduced CtDsbA-SSS differs from that of reduced wild type 397 
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CtDsbA : 339 ± 0.2 K (reduced wild-type CtDsbA) and 336K ± 0.1 (reduced CtDsbA-SSS) 398 
(Table 1). This is most likely a result of differences in the biochemical properties of the serine 399 
compared to the reduced cysteine residue that it replaces. Together these mutations may 400 
additionally alter the overall stability of CtDsbA-SSS and contribute to the difference in 401 
melting temperature of reduced CtDsbA-SSS relative to reduced CtDsbA.  402 
 403 
Table 1. Melting temperatures of CtDsbA redox states. 404 
 Tm (K) reduced Tm (K) oxidized ∆Tm (K) 
CtDsbA 339±0.2 335±0.1 4 
CtDsbA-SSS 336±0.1 334±0.2 2 
The melting temperatures (Tm) of reduced and oxidised CtDsbA were determined 405 
previously [36]. Tm values for CtDsbA-SSS are from this study. Mean and SD for three 406 
biological replicates are presented. 407 
 408 




We have identified a DsbB protein in C. trachomatis, and demonstrated that it is a redox 411 
partner of the previously characterised oxidase CtDsbA [36]. As a redox pair CtDsbA and 412 
CtDsbB largely resemble their homologous counterparts in E. coli: CtDsbA is directly 413 
oxidised by CtDsbB in a reaction in which both periplasmic cysteine pairs of CtDsbB are 414 
required for activity. We showed that this reaction proceeded independent of exogenously 415 
added ubiquinone, but more slowly than the EcDsbA-EcDsbB interaction and did not go to 416 
completion. Whilst these data demonstrate that CtDsbA and CtDsbB form a redox relay, 417 
they suggest that the native CtDsbB co-factor is not UQ1 or Ubiquinone-8 (UQ8) (the 418 
endogenous ubiquinone in E. coli).  419 
 420 
A notable difference from the canonical E. coli system in C. trachomatis is the presence of 421 
a second non-catalytic disulfide bond in CtDsbA. This disulfide bond, bridging helices H2 422 
and H5 of the protein, is conserved in DsbAs from alpha-proteobacteria including W. 423 
pipientis [49]. It is also found in the DsbA from M. tuberculosis [34] and one of the two DsbAs 424 
(PaDsbA2) encoded by P. aeruginosa [32]. In W. pipientis, this second disulfide has a 425 
modest effect on redox potential [33] but appears to inhibit the WpDsbA interaction with 426 
WpDsbB [49]. By contrast, the additional disulfide bond of PaDsbA2 does modulate the 427 
protein’s redox potential [32]. For CtDsbA, we found that this second disulfide bond has no 428 
effect on CtDsbA activity or its interaction with CtDsbB but may contribute to the relative 429 
stability of the active site redox forms of the enzyme.  430 
 431 
Reduced EcDsbA is partially oxidised immediately upon addition of EcDsbB and UQ1, and 432 
becomes fully oxidised after 10 seconds [48]. We observe a similar trend for the Chlamydia 433 
proteins, supporting the observation that CtDsbA and CtDsbB are partners, but conclude 434 
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also that the reaction is not optimal under the experimental conditions we used. This may 435 
reflect the fact that the proteins were expressed recombinantly in a non-native E. coli host.  436 
 437 
Inaba et al have reported that a quinone-free preparation of EcDsbB oxidises ~40% of 438 
EcDsbA in a 1:1 stoichiometric reaction [48]. This may also be the case for the Chlamydia 439 
DsbA/B system as we found that about half of reduced CtDsbA or CtDsbA-SSS is oxidised 440 
by CtDsbB in a 1:1 ratio. The addition of exogenous UQ1 to the CtDsbB reaction had no 441 
further effect, indicating that UQ1 or endogenous UQ8 (presumed to be present in E. coli 442 
membranes), may not be its optimal cofactor.  443 
 444 
Members of the Chlamydia genus are Gram negative obligate intracellular bacteria with a 445 
biphasic development cycle. In this cycle, Chlamydia alternates between two different cell 446 
types, the infectious extracellular EB and the intracellular RB, although this is highly 447 
asynchronous. After the infectious EBs have been internalised by host eukaryotic cells, the 448 
EBs differentiate to RBs (2-8 h post infection). The RBs subsequently replicate (8-24 h), 449 
before re-differentiating to EBs (24-72 h) in preparation for cell lysis or vacuole extrusion 450 
and release (40-72 h), ready for the next infectious event. Confocal microscopy with 451 
immunofluorescence detected CtDsbA in C. trachomatis from at least 20 h post infection 452 
onwards (also observed by Western blot). The 20 h time point represents the middle to late 453 
replicative phase of the Chlamydia biphasic lifecycle, when the recently differentiated RBs 454 
multiply. A previous transcriptional profiling study reported that CtDsbA gene expression 455 
begins as soon as 8 hours post infection [50], corresponding to late EB to RB differentiation 456 
and early RB replication. We were able to detect DsbA at 20 h PI using immunofluorescence 457 
microscopy, and a faint band via Western blot. The low levels of CtDsbA protein detected at 458 
20 h post infection could arise from the use of different strains in the two studies (C. 459 
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trachomatis serovar D strain UW-3/Cx in the transcriptional study compared to C. 460 
trachomatis LGV-2 used here), but more likely reflects a difference in methodology for 461 
detecting CtDsbA (transcript versus protein). Factors such as mRNA stability, protein 462 
degradation, and variable transcription and translation rates, mean that mRNA expression 463 
levels can differ by up to 60% from protein levels in eukaryotes and prokaryotes [51, 52]. A 464 
third study measured CtDsbA protein levels by label-free quantitative proteomics and found 465 
no DsbA in replicating RBs 18 h post infection, but did detect CtDsbA in EBs 44 h post 466 
infection, around the time of asynchronous exit from the host cell [53]. In our hands, CtDsbA 467 
protein levels increased markedly between 20 and 32 h PI and remained at a high level at  468 
44 h post infection. In summary, CtDsbA protein was detectable at 20 h post infection, 469 
although CtDsbA transcription onset may precede this by up to 12 hours.  470 
 471 
Within the C. trachomatis COMC, the MOMP is synthesised early in the replicative phase 472 
but is not oxidised until the onset of RB to EB differentiation (at approximately 24 h post 473 
infection) [22, 38, 39, 50, 54, 55]. The two cysteine-rich proteins, OmcA and OmcB are 474 
synthesised late in the replicative phase (up to 24 h post infection) but are oxidised 475 
immediately [22, 38, 39, 50, 54]. The coincidence of CtDsbA expression and the onset of 476 
COMC protein oxidation is notable, and could support the notion that the COMC is one 477 
possible substrate of CtDsbA. DsbJ and DsbH are also likely to be important contributors to 478 
the COMC protein redox status. The expansion of the number of genes encoding for 479 
oxidoreductases in Chlamydia is likely due to the critical role that redox status has on the 480 
developmental cycle, mediated by the COMC. Presumably given the reduced genome 481 
nature of this organism, the oxidoreductases are likely all critical. It is possible that individual 482 
proteins have specialised substrate selectivity or, given how critical the redox status of the 483 
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COMC is for the biology of this organism, that there is functional redundancy, although the 484 
precise function of individual oxidoreductases in Chlamydia is currently unknown [20]. 485 
 486 
Disulfide-dependent infection and development is a unique feature of Chlamydia, though 487 
the suite of Dsb proteins in Chlamydia are, with the exception of DsbJ, present in other 488 
bacteria (reviewed in [20]). Continued elucidation of the intricacies of Chlamydia Dsb 489 
proteins, their substrates, and their interaction will help us to understand the critical yet 490 




Materials and Methods 493 
Investigation of CtDsbA expression levels by Western blot 494 
McCoy B (sourced from American Tissue Culture Collection (ATCC): CRL 1696, mouse 495 
fibroblast like immortalised cells) cells were cultured in 6-well plates at 300,000 cells per 496 
well in 3 mL of culture media (high glucose Dulbecco’s Modified Eagle Medium (DMEM; 497 
Sigma-Aldrich D6546) supplemented with heat-inactivated 10% foetal calf serum, 4 mM L-498 
Glutamine,100 μg/mL streptomycin and 50 μg/mL gentamycin) and incubated at 37˚C with 499 
5% CO2. 24 hours after seeding, cells were infected with C. trachomatis LGV-2 (strain 500 
443/Bu, sourced from the ATCC: VR-902B ) at a multiplicity of infection of 1. The infected 501 
cells were rocked for 30 mins to disperse infectious units, then centrifuged at 500 × g for 30 502 
mins to synchronise the infection, prior to a media change at 4 h post infection (h PI) with 503 
the addition of 1 µg/mL cycloheximide. Uninfected controls were cultured in the same 504 
manner except non-infectious media was added at 24 h after seeding. Infected wells were 505 
harvested into SPG (10 mM sodium phosphate, 250 mM sucrose, 5 mM L-glutamate) via 506 
scraping at 20, 32 and 44 h PI, and uninfected wells were harvested at 44 h PI only. Two 507 
sets of triplicate wells were pooled for each sample and immediately added to 4x Bolt LDS 508 
Sample Buffer (Invitrogen; lithium dodecyl sulfate at pH 8.4) to give a final concentration of 509 
1x sample buffer and 50 mM dithiothreitol (DTT), and boiled at 99°C for 20 mins to lyse. 510 
Independent experiments were repeated on three separate occasions. A representative 511 
example Western blot is shown in the results. For Western blot analysis samples were 512 
separated by SDS-PAGE using Bolt 4-12% Bis-Tris gels (Thermofisher) in MES SDS 513 
running buffer (50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 7.3) at 200 V 514 
for 20 min. Following electrophoresis, proteins were transferred onto a nitrocellulose 515 
membrane using an iBlot 2 transfer device (Thermofisher). Proteins were probed with an 516 
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anti-CtDsbA antibody from serum harvested from a rabbit immunised with purified 517 
recombinant CtDsbA protein (purchased from Osenses). The serum containing anti-CtDsbA 518 
antibody was prepared as a 1:400 dilution in 1% skim milk powder in TBS (50 mM Tris-Cl, 519 
pH 7.6, 150 mM NaCl). An anti-RpoB antibody (Chlamydia loading control, MyBioSource) 520 
was similarly prepared in a 1:20,000 dilution, and anti-MOMP (second Chlamydia loading 521 
control, Invitrogen) was prepared as a 1:5000 dilution. Anti-rabbit IgG, or anti-mouse IgG 522 
coupled with horse radish peroxidase were applied as a secondary antibody (1:10,000 523 
dilution in 1% skim milk powder in TBS) and the final bound protein detected using enhanced 524 
chemiluminescence (Amersham ECL Prime Western Blotting Detection Reagent, GE 525 
Healthcare) and an Amersham AI600 imager (GE Healthcare).       526 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    527 
Investigation of CtDsbA protein by confocal microscopy 528 
At 20, 32 and 44 h post infection, coverslip cultures of McCoy B cells infected with C. 529 
trachomatis LGV-2 were fixed with 4% PFA for 10 min. Cultures were stained with the anti-530 
CtDsbA antibody used for the Western blot analysis, and a secondary goat anti-rabbit IgG 531 
antibody conjugated with Alexa Flour 488. Positive labelling controls were stained with anti-532 
CtHtrA antibody raised in rabbit and the same secondary used against anti-CtDsbA. The 533 
host cell nucleus was stained with 4′,6-diamidino-2-phenylindole (DAPI), and the host cell 534 
cytoskeleton was stained with Alexa Fluor 594 Phalloidin. Coverslips were mounted on 535 
slides in Prolong Gold (Invitrogen) prior to immunofluorescence imaging on a Nikon A1 536 




Expression and purification of CtDsbA and variants 539 
The recombinant CtDsbA used in this study corresponds to residues 34-238 of C. 540 
trachomatis dsbA  as reported previously [36]. CtDsbA-SSS is a variant in which each of 541 
three non-active cysteines are mutated to serine (C66S, C80S and C141S). CtDsbA and 542 
CtDsbA-SSS were expressed in E. coli BL21 (DE3) pLysS (Invitrogen) and purified as 543 
described in [36] with one modification; to improve stability of the protein the buffer was 544 
changed to 25 mM Tris pH 7.4, 150 mM NaCl. As required CtDsbA and CtDsbA-SSS were 545 
reduced and oxidised by incubation with 100-fold molar excess of dithiothreitol (DTT) or 100 546 
fold molar excess of oxidised glutathione, respectively. The protein redox state was 547 
confirmed by Ellman’s reagent [56]. 548 
 549 
Expression and preparation of membranes containing CtDsbB 550 
and variants 551 
CtDsbB (Uniprot ID 084179) was identified by homology to EcDsbB (Fig 3). Additional 552 
CtDsbB variants in which pairs of cysteine residues in each of the periplasmic loops were 553 
mutated to serine were also designed: namely CtDsbB-SSCC (C36S and C39S in 554 
periplasmic loop 1) and CtDsbB-CCSS (C98S and C104S in periplasmic loop 2). The DNA 555 
for CtDsbB and mutants were purchased as gBlocks (Integrated DNA technologies) with a 556 
5’ XhoI and a 3’ NdeI restriction site for insertion to a pET21a vector. This added a non-557 
cleavable C-terminal His6 tag. 558 
 559 
All constructs were expressed in E. coli C41(DE3) (kindly provided by Cy Jeffries, University 560 
of Sydney) cells using PASM 5052 autoinduction media [57] containing ampicillin and 561 
incubated at 30°C for 18-24 h with orbital shaking at 200 rpm. Cells were harvested by 562 
centrifugation at 6,000 rpm for 15 mins. Harvested cells were resuspended in 25 mM 2-(N-563 
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morpholino) ethanesulfonic acid (MES) buffer at pH 6, 150 mM NaCl and lysed using a cell 564 
disrupter (Constant Systems Ltd) (one passage at 28 KPsi followed by a second passage 565 
at 30 KPsi). Unbroken cells and debris were removed by centrifugation at 18,500 rpm for 30 566 
mins. Membranes were harvested from the supernatant by ultracentrifugation (42,000 rpm 567 
for 1 hr) at 4°C. The pellet was resuspended in 25 mM MES pH 6, 150 mM NaCl using a 568 
glass dounce homogeniser.  569 
 570 
For the model substrate folding assay, the amount of CtDsbB present in the crude 571 
membranes was quantified by SDS-PAGE analysis, in comparison to a series of known 572 
amounts of detergent solubilised purified EcDsbB (0, 0.5, 1, 2 and 5 μg). A series of dilutions 573 
of the membrane preparation were prepared in sample loading dye alongside EcDsbB 574 
standards, and densiometric analysis and comparison of the bands used to estimate the 575 
concentration of CtDsbB in the membrane preparations.  576 
 577 
Solubilisation and purification of CtDsbB 578 
Crude membranes containing CtDsbB were solubilised in 25 mM MES pH 6, 150 mM NaCl 579 
with 0.5 % DDM under vigorous stirring at 4°C for 1 h. Solubilised protein was isolated by 580 
ultracentrifugation for 1 h at 42,000 rpm at 4°C, and the supernatant loaded onto a 5 mL 581 
HisTrapTM HP column (GE Healthcare) equilibrated in 25 mM MES pH 6, 150 mM NaCl with 582 
0.015 % DDM (Buffer 1).  The column was washed with Buffer 1 plus 20 mM imidazole (10 583 
x column volume (CV)), with sequential washes of 40 mM imidazole (10 x CV), 80 mM 584 
imidazole (10 x CV), 120 mM imidazole (5 x CV) and eluted with 500 mM imidazole (5 x 585 
CV). The eluted protein has a distinctive orange colour, suggesting a bound ubiquinone 586 
cofactor [48]. Protein was further purified by size exclusion chromatography using a 587 
SuperdexTM 200 16/60 column (GE Healthcare) in Buffer 1. Protein purity was evaluated by 588 
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SDS-PAGE on a NuPAGE 12% Bis-Tris gel (Thermofisher) with MES running buffer (50 mM 589 
MES pH 7.3, 50 mM Tris, 0.1% sodium dodecyl sulfate (SDS) and 1 mM 590 
Ethylenediaminetetraacetic acid (EDTA)). 591 
Model substrate folding assay  592 
The peptide oxidation assay was performed as reported in [36] except that crude 593 
membranes containing recombinant CtDsbB were used instead of oxidised glutathione to 594 
sustain CtDsbA activity. Briefly the assay was performed in a 384-well plate (Perkin Elmer, 595 
USA). A solution of 50 mM MES, 50 mM NaCl, 2 mM EDTA, pH 5.5, 8 μM of the DsbB and 596 
either 80 nM (EcDsbA) or 640 nM (CtDsbA or CtDsbA-SSS) were added to the wells in a 597 
total volume of 25 μL. Adding 25 μL peptide to a final concentration of 10 μM started the 598 
reaction. Change in fluorescence was monitored at excitation 340 nm and emission 615 nm, 599 
with a delay of 100 µs and read time of 100 µs, using a Synergy H1 Multimode plate reader 600 
(BioTek, USA). Plotted data shows mean and SD for two biological replicates. 601 
 602 
Redox state of analysis of reduced CtDsbA and CtDsbA-SSS in 603 
the presence of CtDsbB using gel-shift assay 604 
Purified reduced CtDsbA or CtDsbA-SSS (15 μM) were mixed with equimolar amounts of 605 
detergent solubilised purified CtDsbB (15 μM) in the presence or absence of equimolar 606 
amounts of UQ1 (15 μM) in 25 mM MES pH 6, 150 mM NaCl, and 0.1% DDM in a total 607 
volume of 60 μL. 5 μL samples were taken immediately after adding CtDsbB (t = 0 mins), 608 
and then after 10, 20, 30, 60, 90 and 120 min incubation, before trichloroacetic acid (TCA) 609 
10 % w/v mediated precipitation, washing with ice-cold acetone, labelling with 4-acetamido-610 
4’-maleimidylstilbene-2,2’-disulfonic acid (AMS) and SDS-PAGE analysis as described 611 
previously [36]. Control reactions included reduced CtDsbA/CtDsbA-SSS with UQ1 (15 μM), 612 
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CtDsbA/CtDsbA-SSS with 5 mM oxidised glutathione (GSSG), and CtDsbA/CtDsbA-SSS 613 
with 5 mM DTT incubated for 2 hrs. Data presented is representative of three independent 614 
experiments from three different purifications of recombinant CtDsbA, CtDsbA-SSS and 615 
CtDsbB, expressed following independent transformations of E. coli.  616 
 617 
Relative stability of oxidised and reduced forms of CtDsbA-SSS 618 
The thermal stability of reduced and oxidised CtDsbA-SSS was determined by circular 619 
dichroism using a Jasco J-810 circular dichroism (CD) spectropolarimeter. Measurements 620 
were carried out with 10 μM protein in 100 mM NaH2PO4/Na2HPO4, 0.1 mM EDTA, pH 7.0 621 
in a 1 mm quartz cuvette. The unfolding was monitored as a change in molar ellipticity at 622 
220 nm with a heat rate of 0.5 K/min from 298 K to 398 K. Plotted data shows mean and SD 623 
for two biological replicates. 624 
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